These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer. Huang X; Hu P; Yan F; Zhang J Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800 [No Abstract] [Full Text] [Related]
3. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer. Qiu C; Dong W; Su B; Liu Q; Du J J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database. Yang H; Mei T Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790 [TBL] [Abstract][Full Text] [Related]
6. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database. Zhang N; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H Int J Surg; 2020 Feb; 74():44-52. PubMed ID: 31874262 [TBL] [Abstract][Full Text] [Related]
7. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients. Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129 [TBL] [Abstract][Full Text] [Related]
8. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients]. Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316 [TBL] [Abstract][Full Text] [Related]
9. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer. Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846 [TBL] [Abstract][Full Text] [Related]
10. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study. Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824 [No Abstract] [Full Text] [Related]
11. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer. Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195 [TBL] [Abstract][Full Text] [Related]
12. The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival. Yang J; Long Q; Li H; Lv Q; Tan Q; Yang X J Thorac Dis; 2017 Jun; 9(6):1531-1537. PubMed ID: 28740666 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Relevance of Negative Lymph Node Count in Resected Stage I-IIIa Small-cell Lung Cancer. Yang H; Li D; Liu T Am J Clin Oncol; 2023 Jul; 46(7):306-313. PubMed ID: 37102621 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma. Li X; Lin H; Sun Y; Gong J; Feng H; Tu J J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756 [TBL] [Abstract][Full Text] [Related]
15. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis. Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199 [TBL] [Abstract][Full Text] [Related]
16. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study. Fan Y; Du Y; Sun W; Wang H Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778 [TBL] [Abstract][Full Text] [Related]
17. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database. Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925 [TBL] [Abstract][Full Text] [Related]
18. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? David EA; Cooke DT; Chen Y; Nijar K; Canter RJ; Cress RD Ann Thorac Surg; 2017 Jan; 103(1):226-235. PubMed ID: 27469339 [TBL] [Abstract][Full Text] [Related]
19. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer. Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460 [TBL] [Abstract][Full Text] [Related]
20. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less. Ding H; Wang H; Xu L; Song N; Jiang G Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]